Acute Rheumatic Fever (ARF) is an autoimmune response to untreated or inadequately treated Group A Streptococcus infections, particularly streptococcal pharyngitis. Primarily affecting children and adolescents, ARF can manifest with a range of symptoms, including arthritis, carditis, skin rash, subcutaneous nodules, and Sydenham's chorea. The inflammatory response in ARF is directed against various tissues, particularly the heart, joints, and skin. Carditis is a significant component of ARF, potentially leading to rheumatic heart disease (RHD), a chronic condition characterized by valvular damage. The mitral valve is commonly affected, resulting in mitral stenosis or regurgitation. Recurrent episodes of ARF can exacerbate valvular lesions, contributing to the progression of RHD. Diagnosis of ARF involves the Jones criteria, which consider clinical manifestations, laboratory findings, and evidence of a preceding streptococcal infection. Treatment includes antibiotics to eliminate the streptococcal infection and anti-inflammatory medications such as aspirin or corticosteroids to manage symptoms and reduce inflammation. Prevention of ARF recurrence and subsequent RHD involves long-term antibiotic prophylaxis. This prophylaxis is crucial in individuals with a history of ARF to prevent further streptococcal infections and subsequent autoimmune responses. Public health efforts also focus on early detection and prompt treatment of streptococcal infections to minimize the risk of ARF development.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation